pioglitazone has been researched along with natriuretic peptide, c-type in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, TH; Doi, K; Fukunaga, Y; Hosoda, K; Inoue, M; Itoh, H; Kook, H; Masatsugu, K; Nakao, K; Saito, T; Sawada, N; Tanaka, T; Ueda, M; Yamashita, J | 1 |
1 other study(ies) available for pioglitazone and natriuretic peptide, c-type
| Article | Year |
|---|---|
Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Topics: Animals; Arteriosclerosis; Carotid Arteries; Cattle; Cell Division; Cells, Cultured; Chromans; Coronary Vessels; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Gene Expression; Humans; Hypoglycemic Agents; Natriuretic Peptide, C-Type; Pioglitazone; Radioimmunoassay; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Vasodilator Agents; Vasomotor System | 2001 |